Skip to content

Insider · CIK 0001844838

Matthew Doctor

ceopresidentofficerdirector

Files at RGS (REGIS CORP). First filing -, latest -.

Matthew Doctor files SEC Form 4 as CEO, president and director at RGS (REGIS CORP). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.

A track record needs three past buys with six months of prices behind them; Matthew Doctor has 0, so none is measured yet.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Planned sales

Form 144 notices this insider filed before selling restricted or control stock, newest first.

FiledCompanySharesValueSale datePast 3 months
Oct 24, 2025 RGS
REGIS CORP
704
0.03% of outstanding
$21kOct 24, 2025$398k
Oct 20, 2025 RGS
REGIS CORP
745
0.03% of outstanding
$23kOct 20, 2025$376k
Oct 15, 2025 RGS
REGIS CORP
1,897
0.08% of outstanding
$58kOct 15, 2025$318k
Sep 26, 2025 RGS
REGIS CORP
437
0.02% of outstanding
$12kSep 26, 2025$305k
Sep 19, 2025 RGS
REGIS CORP
937
0.04% of outstanding
$27kSep 19, 2025$278k
Sep 18, 2025 RGS
REGIS CORP
9,626
0.40% of outstanding
$278kSep 18, 2025none

Transactions

Every row this insider has filed, 3 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Nov 22, 2024RGS
REGIS CORP
AGrant or award
Common Stock
+16,500$0.00$019,584Nov 26, 2024
Nov 5, 2024RGS
REGIS CORP
FTax withholding
Common Stock
-547$23.37$13k3,084Nov 19, 2024
Nov 5, 2024RGS
REGIS CORP
FTax withholding
Common Stock
-339$23.37$7,9223,292Nov 7, 2024

Questions about Matthew Doctor

Answered from the filings on this page, as of the latest one.

Is Matthew Doctor buying or selling?

Matthew Doctor has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.

How did Matthew Doctor's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Matthew Doctor has 0.

Where does Matthew Doctor file Form 4?

Matthew Doctor has filed Form 4 at RGS (REGIS CORP) as President and CEO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Matthew Doctor: insider trades and track record | InsiderTell